Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
24
Number of overlapping holdings
82.8%
% of PBE's 29 holdings also in IBB
9.6%
% of IBB's 265 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus IBB)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in IBB |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 5.2% | 9.6% | 5.2% |
|
VERTEX PHARMACEUTICALS INC | 5.1% | 8.6% | 5.1% |
|
GILEAD SCIENCES INC | 5.1% | 8.0% | 5.1% |
|
REGENERON PHARMACEUTICALS | 5.1% | 8.3% | 5.1% |
|
BIOGEN IDEC INC | 5.0% | 3.5% | 3.5% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to IBB
|
UNITED THERAPEUTICS CORP | 3.9% |
|
INCYTE CORP | 3.7% |
|
BIOMARIN PHARMACEUTICAL INC | 3.5% |
|
CATALENT INC | 3.1% |
|
VERICEL CORPORATION | 3.0% |
|
OPKO HEALTH INC | 2.7% |
|
QIAGEN NV | 2.6% |
|
PACIFIC BIOSCIENCES OF CALIF | 2.6% |
|
AMICUS THERAPEUTICS INC | 2.6% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 2.6% |
PBE Underweight Relative to IBB
|
AMGEN INC | -4.3% |
|
IQVIA HOLDINGS INC | -3.7% |
|
SEATTLE GENETICS INC | -3.7% |
|
MODERNA, INC. | -3.6% |
|
VERTEX PHARMACEUTICALS INC | -3.5% |
|
REGENERON PHARMACEUTICALS | -3.3% |
|
GILEAD SCIENCES INC | -2.8% |
 |
METTLER-TOLEDO INTERNATIONAL | -2.4% |
 |
ARGENX SE ADR | -2.3% |
|
ILLUMINA INC | -2.2% |